InsiderFlow

Christopher Gibson

RXRX

Christopher Gibson serves as director at Recursion Pharmaceuticals, Inc. (RXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

72 trades

$39.02M

Net Position

Net Seller

$39.02M

Companies Traded

1

RXRX

Active Period

Dec 2021 – Apr 2026

72 total trades

Most Recent

Sell RXRX

Apr 24, 2026 · $144.4K

Christopher Gibson's Insider Trading at Recursion Pharmaceuticals, Inc. (RXRX)

Buys

0 · $0.00

Sells

22 · $15.22M

Total Shares Bought

0

Total Shares Sold

1,725,447

RXRX Price Chart
Loading chart...
DateTypeValue
Sep 2, 2022 Sell$393.7K
Aug 5, 2022 Sell$363.6K
Jul 8, 2022 Sell$349.6K
Jun 6, 2022 Sell$257.6K
May 6, 2022 Sell$357.9K
May 2, 2022 Sell$489.3K
Apr 25, 2022 Sell$488.1K
Apr 20, 2022 Sell$255.1K
Apr 18, 2022 Sell$272.1K
Apr 12, 2022 Sell$253.3K
Apr 11, 2022 Sell$256.5K
Apr 8, 2022 Sell$259.1K
Apr 7, 2022 Sell$267.2K
Mar 15, 2022 Sell$2.18M
Mar 9, 2022 Sell$2.19M
Feb 24, 2022 Sell$1.02M
Feb 2, 2022 Sell$233.0K
Jan 14, 2022 Sell$4.69M
Dec 20, 2021 Sell$4.0K
Dec 15, 2021 Sell$2.0K
Dec 10, 2021 Sell$236.6K
Dec 9, 2021 Sell$405.4K

Showing 5172 of 72